Bate Kenneth
Director at MDGL; Director at CUBIST PHARMACEUTICALS INC
- Sold, on record
- $29.5M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Nov 5, 2025
- Form 144 notices
- 4
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MDGLMADRIGAL PHARMACEUTICALS, INC.Director
- CUBIST PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MDGL79,064 shares
- CUBIST PHARMACEUTICALS INC38,750 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice MDGLNoticeApr 1, 2024 2024
Filed to sell 32,489 shares ($8.7M)
Bate Kenneth, Director
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale MDGLRoutineApr 2, 2024 +1 day
Sold 32,489 shares at $252.86 ($8.2M)
Bate Kenneth, Director
10b5-1 planSold 96.4% of holdings ($8.5M position)1,198 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice MDGLNoticeFeb 27, 2025 +331 days
Filed to sell 20,000 shares ($7.1M)
Bate Kenneth, Director
No 10b5-1 planFiling
- 4 Form 4 sale MDGLUnusualFeb 27, 2025 same day
Sold 20,000 shares at $356.44 ($7.1M)
Bate Kenneth, Director
No 10b5-1 planSold 91.3% of holdings ($7.8M position)1,912 shares leftFollows a Form 144Filing
- 5 Form 144 notice MDGLNoticeAug 15, 2025 +169 days
Filed to sell 10,000 shares ($3.7M)
Bate Kenneth, Director
No 10b5-1 planFiling
- 6 Form 4 sale MDGLUnusualAug 15, 2025 same day
Sold 10,000 shares at $365.20 ($3.7M)
Bate Kenneth, Director
No 10b5-1 planSold 79.2% of holdings ($4.6M position)2,627 shares leftFollows a Form 144Filing
- 7 Form 144 notice MDGLNoticeNov 5, 2025 +82 days
Filed to sell 16,575 shares ($8M)
Bate Kenneth, Director
No 10b5-1 plan0.8x usual sizeFiling
- 8 Form 4 sale MDGLUnusualNov 5, 2025 same day
Sold 16,575 shares at $484.31 ($8M)
Bate Kenneth, Director
No 10b5-1 planSold 86.3% of holdings ($9.3M position)2,627 shares left0.8x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Nov 7, 2025 | MDGL | Director | Form 4 sale | 16,575 | $8M | 86.3% | Unusual | SEC |
| Nov 5, 2025 | Nov 5, 2025 | MDGL | Director | Form 144 notice | 16,575 | $8M | Notice | SEC | |
| Aug 15, 2025 | Aug 15, 2025 | MDGL | Director | Form 4 sale | 10,000 | $3.7M | 79.2% | Unusual | SEC |
| Aug 15, 2025 | Aug 15, 2025 | MDGL | Director | Form 144 notice | 10,000 | $3.7M | Notice | SEC | |
| Feb 27, 2025 | Feb 28, 2025 | MDGL | Director | Form 4 sale | 20,000 | $7.1M | 91.3% | Unusual | SEC |
| Feb 27, 2025 | Feb 27, 2025 | MDGL | Director | Form 144 notice | 20,000 | $7.1M | Notice | SEC | |
| Apr 2, 2024 | Apr 3, 2024 | MDGL | Director | Form 4 sale | 32,489 | $8.2M | 96.4% | Routine | SEC |
| Apr 1, 2024 | Apr 1, 2024 | MDGL | Director | Form 144 notice | 32,489 | $8.7M | Notice | SEC | |
| Feb 3, 2014 | Feb 4, 2014 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 6,250 | $451k | 44.1% | Unusual | SEC |
| Jan 9, 2014 | Jan 9, 2014 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 10,000 | $700k | 55.8% | Unusual | SEC |
| Dec 2, 2013 | Dec 3, 2013 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 12,500 | $845k | 61.2% | Unusual | SEC |
| Jun 3, 2013 | Jun 3, 2013 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 2,500 | $137k | 30.0% | Unusual | SEC |
| May 15, 2013 | May 17, 2013 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 2,500 | $121k | 30.0% | Unusual | SEC |
| Mar 6, 2013 | Mar 7, 2013 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $238k | 46.1% | Unusual | SEC |